“As a result of Lewis solely complained of regulatory, quite than fraudulent, violations in his inner communications with AbbVie, the corporate had no purpose to assume Lewis’s issues revolved across the False Claims Act. Extra merely, AbbVie couldn’t have retaliated towards Lewis as a fraud whistleblower as a result of he by no means blew the whistle on fraud, U.S. Courtroom of Appeals for the Seventh Circuit Decide Joshua P. Kolar stated.
Trending
- Why does your house smell weird once you enter? Get rid of the stink with these tips | Lifestyle News
- ‘Unhe nahi pata aapki skin type kya hai…’: Rubina Dilaik says no to parlour facials — should you too? | Lifestyle News
- Spilled oil in the kitchen? Don’t reach for tissues first — try this hack instead | Lifestyle News
- Mira Kapoor has adopted these 3 Ayurvedic principles in her life: ‘Gives an entire map of how your body functions’
- Optimize Your Budget With a $50 Sam’s Club Membership and $35 in Rewards
- A nutritionist analyses celebrity Chef Pankaj Bhadouria’s technique of frying papad, fryums, and chips without oil | Food-wine News
- Airport fashion: Here’s some style inspiration for your next flight | Fashion News
- Is This Where Future Business Owners Will Start Their Education?
Sunday, September 7
Former AbbVie Sales Rep's Fraud Claims Tossed in Whistleblower Suit, 7th Circuit Rules
